Process Licensing Office joins the MHRA

Published: 1-Aug-2018
Regulatory


The UK"s MHRA Inspectorate has announced the incorporation of the Process Licensing Office to the Inspectorate to become the Inspectorate & Process Licensing Group

The Process Licensing Office is responsible for:

  • Processing Initial and Variation Applications for Wholesale Distribution Authorisations, Broker Registrations and Manufacturing Licences
  • Processing Registration applications, variations and annual reports for Manufacturers, Importers and Distributors of active substances
  • Issuing Licences
  • Issuing and Re-Issuing GMP/GDP/GLP Certificates
  • Issuing Export Certificates for Pharmaceutical companies who wish to export products from the UK to another market. These Certificates are issued under the World Health Organisation (WHO) Certificate scheme
  • Answering Freedom of Information (FoI) requests on behalf of IE&S

This change forms part of the ongoing Transformation programme at MHRA and is effective from 1st August 2018.

  • Companies:
  • MHRA
See more

You may also like

Regulatory

UK signs healthcare-focused Memorandum with Russia

Read more
The Medicines and Healthcare products Regulatory Agency has signed a Memorandum of Understanding with its Russian counterpart

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    What is ISO 8 cleanroom classification? Each cleanroom class is denoted by a maximum concentration of particles per cubic meter or cubic foot of air. ISO 8 is the second lowest cleanroom classification
  2. The three musketeers of pharmaceutical quality control GMP, GAMP5, and 21CFR11 explained
  3. A guide to cleanroom wall systems Discover the best wall panel options for your cleanroom’s performance and compliance needs
  4. Microbiological monitoring: Adapting to new rapid methods regulatory demands Dr Wan Li Low from Cherwell takes a look at the shift towards Rapid Microbiology Methods (RMM) and their validation
  5. PBSC 35 Years of Excellence - Established in 1987, PBSC has become one of the leading manufacturers of Clean Room, High Containment and Material Decontamination products throughout the world.

Upcoming event

EMPQ Essentials and Real-World Strategies for Successful Cleanroom Qualifications

16 January 2025 | Virtual See all

You may also like

Regulatory

UK signs healthcare-focused Memorandum with Russia

The Medicines and Healthcare products Regulatory Agency has signed a Memorandum of Understanding with its Russian counterpart
Ingredients

Protak Scientific's enzymatic indicator gains MHRA support

The UK's Medicines and Healthcare products Regulatory Agency has agreed to form a focus group to discuss the use of enzymatic indicators for decontamination validation
Regulatory

MHRA publishes GXP data integrity guide

Latest document comprises Good Clinical Practice, Good Distribution Practice, Good Laboratory Practice, Good Manufacturing Practice and Good Pharmacovigilance Practice
Regulatory

Annex 1 sterile medicinal product manufacture conference approaches

Cherwell Laboratories, specialist supplier of products for environmental monitoring and process validation, will be exhibiting and participating in a key <i>EU GMP Annex 1 Draft Revision Insight</i> meeting at Leamington Spa on 12 March
Regulatory

Wickham Laboratories announces successful MHRA GMP inspection

Wickham Laboratories reports a successful completion of the MHRA audit process and the subsequent renewal of its GMP accreditation
You need to be a subscriber to read this article.
Click here to find out more.
Design & Build

Pharmaceutical manufacture: new standards and best practice

The 23rd annual Pharmig conference, held in Nottingham in November 2015, brought together expert microbiologists, regulatory inspectors and delegates to discuss recent changes to regulatory guidance, as well as hot topics in biofilm remediation, cleaning and environmental monitoring. Susan Birks reports
Regulatory

Baxter recalls multivitamin powder after glass particles are found

Preliminary investigations point to an isolated event, says MHRA
Subscribe now